✨ The Impossible Dream Machine: A Breakthrough Update
Over the past six months, we've been quietly building the Impossible Dream Machine (IDM) — and its impact is already beyond what we imagined.
Ever since doctors first told me in 2022 that there were around 60 recorded reversals of ALS, I became determined to understand how these extraordinary recoveries happened. ALS patients who once could barely move—some limited to their eyes or a few fingers—are now hiking mountains.
This is staggering.
And unlocking the mechanisms behind these reversals has become one of my life’s greatest priorities.
The science is controversial. Reversal data sits in a gray zone within the medical community. But since my diagnosis four years ago, three more ALS reversals have been formally recognized by Dr. Rick Bedlack at Duke University (pictured below) and ALSReversals.com.
🧠 What We’ve Built So Far
Through a collaboration between Duke Health and the Parkland Center for Clinical Innovation (PCCI), IDM was created with a simple but radical purpose:
To understand ALS more deeply, more precisely, and more personally than ever before.
Our team has spent the last quarter analyzing thousands of data points:
● Symptoms
● Genetics
● Medications and supplements
● And the lived daily experience of ALS patients — like me
From this work, patterns have emerged that have never been seen before:
● Unique “shapes” of disease progression
● Early signals that may predict trajectory
● Drug–gene interactions that could explain why some people progress differently
● Novel biological markers that point toward potential intervention windows
These findings are the beginning of something big.
🚀 What Comes Next (2026 and Beyond)
Based on the discoveries in Phase One, we are preparing for two major breakthroughs:
1. A First-of-Its-Kind Clinical Trial at Duke Health
Pending our phase 2 results, Dr. Bedlack will design and lead a new clinical trial in 2026, using IDM’s discoveries to test new hypotheses with real patients, real biomarkers, and real hope.
2. Competing in the Longitude Prize in ALS
IDM has applied to participate in the Longitude Prize, a global challenge to create the world’s first early-detection test for ALS. The next year will be transformational.
IDM will move:
● From insight → action
● From discovery → validation
● From data → people
To families.
To caregivers.
And maybe one day, to every individual touched by ALS.
🎵 The Impossible Dream Becomes a Movement
I never imagined that a single song: “The Impossible Dream” would become
● The anthem of my life
● A keynote speaking platform
● A data-science machine
● …this newsletter
But here we are.
And I know with complete clarity: This is not me. This is God.
I am simply a vessel answering the call.
Nothing impossible is ever done alone.
The way God has guided me into the center of such creative, scientific, and spiritual transformation continues to awe me every single day. It is proof that the soul always knows its purpose. Our job is to listen, to trust, and to step into the light even when the shadows deepen.
The best way YOU can help is to follow along with the IDM journey, and support in whatever way you are able. Whether that is subscribing to this newsletter with a monthly contribution, or simply watching the podcast episodes on YouTube and leaving a supportive comment, it ALL helps.
💛 Thank You
I am deeply grateful for this community—for your belief, your support, and your energy.
I am living my impossible.
And my hope is that it inspires you to live yours.
With love,
Aaron